260 Beyond Validation Testing: A Sleep Tracker for Longitudinal Data Collection in Operational Environments

SLEEP ◽  
2021 ◽  
Vol 44 (Supplement_2) ◽  
pp. A104-A105
Author(s):  
Jaime Devine ◽  
Evan Chinoy ◽  
Rachel Markwald ◽  
Jaime Devine ◽  
Steven Hursh

Abstract Introduction Sleep tracking wearables are increasingly being validation tested against polysomnography (PSG) and actigraphy, but they may not be ideal for long-term epidemiological sleep studies, or for use in operational environments. A given device’s short battery life, limited data storage capacity, inability to detect naps or estimate sleep architecture, or privacy concerns may discourage researchers from using wearables to collect objective sleep data in real-world settings. The Zulu watch (Institutes for Behavior Resources) is designed to collect longitudinal sleep data in operational populations with irregular sleep patterns, such as long-haul pilots or shift workers. It is capable of on-wrist sleep-wake determination, nap detection, on-wrist sleep depth scoring (i.e., interrupted sleep, light sleep, or deep sleep), on-wrist data storage up to 80 sleep intervals, and year-long battery life. Laboratory testing is an important initial step toward establishing the performance of a device for longitudinal real-world sleep evaluation; therefore, the Zulu watch sleep tracking was subjected to testing against gold-standard PSG and actigraphy. Methods Eight healthy young adult participants (30.4±3.2 years; mean±SD) wore a Zulu watch and Philips Respironics Actiwatch 2 simultaneously over a 3-day laboratory PSG sleep study, with 8 hours time-in-bed each night. Overall epoch-by-epoch agreement of sensitivity (for sleep), specificity (for wake), and accuracy of Zulu watch data were tested against PSG and Actiwatch 2. Results Compared with either PSG or actigraphy, both accuracy and sensitivity for Zulu watch sleep-wake determination were >90% while specificity was low (~26% vs. PSG, ~33% vs. actigraphy). Accuracy for sleep scoring vs. PSG was ~87% for interrupted sleep, ~52% for light sleep, and ~49% for deep sleep. Conclusion The Zulu watch showed mixed results but may be a viable candidate for sleep evaluation based on initial laboratory performance testing in healthy adults. The next steps will be to compare the Zulu watch against self-report of sleep in operational and substance use disorder populations. Longitudinal epidemiological sleep studies can become more feasible if technology is tailored to the specific needs of the real-world environment. Support (if any) Medical Technology Enterprise Consortium award MTEC-17-08-Multi-Topic-0104; Office of Naval Research, Code 34.

SLEEP ◽  
2021 ◽  
Vol 44 (Supplement_2) ◽  
pp. A78-A78
Author(s):  
Zahra Mousavi ◽  
Jocelyn Lai ◽  
Asal Yunusova ◽  
Alexander Rivera ◽  
Sirui Hu ◽  
...  

Abstract Introduction Sleep disturbance is a transdiagnostic risk factor that is so prevalent among emerging adults it is considered to be a public health epidemic. For emerging adults, who are already at greater risk for psychopathology, the COVID-19 pandemic has disrupted daily routines, potentially changing sleep patterns and heightening risk factors for the emergence of affective dysregulation, and consequently mood-related disturbances. This study aimed to determine whether variability in sleep patterns across a 3-month period was associated with next-day positive and negative affect, and affective dynamics, proximal affective predictors of depressive symptoms among young adults during the pandemic. Methods College student participants (N=20, 65% female, Mage=19.80, SDage=1.0) wore non-invasive wearable devices (the Oura ring https://ouraring.com/) continuously for a period of 3-months, measuring sleep onset latency, sleep efficiency, total sleep, and time spent in different stages of sleep (light, deep and rapid eye movement). Participants reported daily PA and NA using the Positive and Negative Affect Schedule on a 0-100 scale to report on their affective state. Results Multilevel models specifying a within-subject process of the relation between sleep and affect revealed that participants with higher sleep onset latency (b= -2.98, p<.01) and sleep duration on the prior day (b= -.35, p=.01) had lower PA the next day. Participants with longer light sleep duration had lower PA (b= -.28, p=.02), whereas participants with longer deep sleep duration had higher PA (b= .36, p=.02) the next day. On days with higher total sleep, participants experienced lower NA compared to their own average (b= -.01, p=.04). Follow-up exploratory bivariate correlations revealed significant associations between light sleep duration instability and higher instability in both PA and NA, whereas higher deep sleep duration was linked with lower instability in both PA and NA (all ps< .05). In the full-length paper these analyses will be probed using linear regressions controlling for relevant covariates (main effects of sleep, sex/age/ethnicity). Conclusion Sleep, an important transdiagnostic health outcome, may contribute to next-day PA and NA. Sleep patterns predict affect dynamics, which may be proximal predictors of mood disturbances. Affect dynamics may be one potential pathway through which sleep has implications for health disparities. Support (if any):


1988 ◽  
Vol 33 (2) ◽  
pp. 103-107 ◽  
Author(s):  
Jonathan A.E. Fleming ◽  
Jean Bourgouin ◽  
Peter Hamilton

Six patients between the ages of 25 and 59, with chronic, primary insomnia received the new, non-benzodiazepine, hypnotic zopiclone continuously for 17 weeks after a drug free interval of 12 nights. To qualify for the study, sleep efficiency, determined by a sleep study on two, consecutive, placebo-controlled nights, had to be less than 75%. Patients evaluated their sleep by questionnaire and had sleep studies completed throughout active treatment. Zopiclone (7.5 mg) increased sleep efficiency by decreasing sleep latency, wakefulness after sleep onset and increasing total sleep time. Sleep architecture was minimally affected by zopiclone treatment; no significant changes in delta or REM sleep were observed. The commonest side effect was a bitter or metallic taste. No significant changes in biological functioning were noted throughout the study period. These findings indicate that zopiclone is a safe and effective hypnotic medication which maintains its effectiveness with protracted use.


2021 ◽  
pp. archdischild-2021-322184
Author(s):  
Susan Jones ◽  
Ross Hanwell ◽  
Tharima Chowdhury ◽  
Jane Orgill ◽  
Kirandeep van den Eshof ◽  
...  

ObjectiveRapid implementation of home sleep studies during the first UK COVID-19 ‘lockdown’—completion rates, family feedback and factors that predict success.DesignWe included all patients who had a sleep study conducted at home instead of as inpatient from 30 March 2020 to 30 June 2020. Studies with less than 4 hours of data for analysis were defined ‘unsuccessful’.Results137 patients were included. 96 underwent home respiratory polygraphy (HRP), median age 5.5 years. 41 had oxycapnography (O2/CO2), median age 5 years. 56% HRP and 83% O2/CO2 were successful. A diagnosis of autism predicted a lower success rate (29%) as did age under 5 years.ConclusionSwitching studies rapidly from an inpatient to a home environment is possible, but there are several challenges that include a higher failure rate in younger children and those with neurodevelopmental disorders.


2019 ◽  
Author(s):  
Md. Jakaria ◽  
Kowshika Sarker ◽  
Mostofa Rafid Uddin ◽  
Md. Mohaiminul Islam ◽  
Trisha Das ◽  
...  

AbstractThe propitious developments in molecular biology and next generation sequencing have enabled the possibility for DNA storage technologies. However, the full application and power of our genomic revolution have not been fully utilized in clinical medicine given a lack of transition from research to real world clinical practice. This has identified an increasing need for an operating system which allows for the transition from research to clinical use. We present eMED-DNA, an in silico operating system for archiving and managing all forms of electronic health records (EHRs) within one’s own copy of the sequenced genome to aid in the application and integration of genomic medicine within real world clinical practice. We incorporated an efficient and sophisticated in-DNA file management system for the lossless management of EHRs within a genome. This represents the first in silico integrative system which would bring closer the utopian ideal for integrating genotypic data with phenotypic clinical data for future medical practice.


2021 ◽  
Author(s):  
Deep Bhattacharjee

Dream is the reflection of our unconscious mind when we are in deep slumber. The duration of dream varies from 14 sec - 40sec and are characterized by Rapid Eye Movement (REM). Dreams occur in the transition period from light sleep to deep sleep or from deep sleep to light sleep. The associated study of dreams is known as Oneirology. It is sometimes associated by physical bodily movement


Bioanalysis ◽  
2021 ◽  
Author(s):  
Scott Davis ◽  
Joel Usansky ◽  
Shibani Mitra-Kaushik ◽  
John Kellie ◽  
Kimberly Honrine ◽  
...  

Challenges for data storage during drug development have become increasingly complex as the pharmaceutical industry expands in an environment that requires on-demand availability of data and resources for users across the globe. While the efficiency and relative low cost of cloud services have become increasingly attractive, hesitancy toward the use of cloud services has decreased and there has been a significant shift toward real-world implementation. Within GxP laboratories, the considerations for cloud storage of data include data integrity and security, as well as access control and usage for users around the globe. In this review, challenges and considerations when using cloud storage options for the storage of laboratory-based GxP data are discussed and best practices are defined.


Proceedings ◽  
2018 ◽  
Vol 2 (18) ◽  
pp. 1174 ◽  
Author(s):  
Isaac Fernández-Varela ◽  
Elena Hernández-Pereira ◽  
Vicente Moret-Bonillo

The classification of sleep stages is a crucial task in the context of sleep medicine. It involves the analysis of multiple signals thus being tedious and complex. Even for a trained physician scoring a whole night sleep study can take several hours. Most of the automatic methods trying to solve this problem use human engineered features biased for a specific dataset. In this work we use deep learning to avoid human bias. We propose an ensemble of 5 convolutional networks achieving a kappa index of 0.83 when classifying 500 sleep studies.


1995 ◽  
Vol 269 (3) ◽  
pp. H952-H958 ◽  
Author(s):  
P. Van de Borne ◽  
P. Biston ◽  
M. Paiva ◽  
H. Nguyen ◽  
P. Linkowski ◽  
...  

This study tested the concept that changes in breathing parameters account for modifications in respiratory-related blood pressure (BP) and R-R interval (RRI) variability during nocturnal sleep. BP (Finapres), electrocardiogram, respiration (Respitrace), and polygraphic sleep recordings were recorded continuously in 13 healthy men aged 18-37 yr. The transfer characteristics identified by coherence and gain measures between the calibrated thoraco-abdominal motion and the respiratory-related BP and RRI variability evidenced a consistent increase during transitions from wake to light sleep and from light to deep sleep but returned to waking levels during rapid-eye-movement sleep (P < 0.0001). These changes were related to the specific modifications occurring in the respiratory rate, tidal volume, and ribcage-to-abdominal motion ratio during the different sleep stages (0.28 < r < 0.39; P < 0.0001). This study demonstrates 1) that modifications in the breathing pattern account for 8-15% of the variance in the cardiorespiratory transfer, and 2) that respiratory modulation of vagal activity is not the main mechanism controlling the magnitude of the respiratory-related BP and RRI variability during sleep.


2018 ◽  
Vol 55 (10) ◽  
pp. 1447-1449 ◽  
Author(s):  
Christina M. Busuito ◽  
Nathan Vandjelovic ◽  
Diana M. Flis ◽  
Arlene Rozzelle

Objective: To determine if sphincter pharyngoplasty changes sleep study parameters on patients undergoing surgery for velopharyngeal insufficiency (VPI). Design: Retrospective chart review on patients undergoing sphincter pharyngoplasty for VPI with pre- and postoperative polysomnography completed. Setting: Institutional study at a tertiary pediatric hospital. Patients: All patients who underwent sphincter pharyngoplasty over a 20-year period were reviewed; all patients with both pre- and postoperative sleep studies were collected for evaluation. Interventions: Sphincter pharyngoplasty for patients with VPI. Main Outcome Measure: Sleep study parameters collected include apnea–hypopnea index (AHI), obstructive and central apneas, hypopneas, and mixed events. The preoperative values were compared to postoperative values. Results: There were 98 patients collected with sleep studies for review. Of these, 32 patients had both pre- and postoperative sleep studies. The AHI increased from 1.8 preoperatively to a postoperative value of 4.8 ( P = .004). The number of obstructive events per night went from 4.6 to 17.6 postoperatively ( P = .04). The number of hypopneas increased from 4.0 to 13.6 ( P = .003). The other parameters were not statistically different, central events decreased from 4.8 to 2.1 ( P = .086), and mixed events were essentially unchanged from 0.2 to 0.5 ( P = .17) events per night. Conclusions: Patients undergoing sphincter pharyngoplasty for VPI may experience an increase in their postoperative AHI, obstructive events per night, and hypopneas. Sleep studies should be performed both pre- and postoperatively to assess the need for intervention or change in management.


SLEEP ◽  
2020 ◽  
Vol 43 (Supplement_1) ◽  
pp. A197-A197
Author(s):  
D Rippole ◽  
J Schirm ◽  
E Nofzinger

Abstract Introduction Forehead cooling has previously been shown to improve EEG sleep measures in insomnia patients when applied for 2 nights. The current study assessed the durability of these effects after 30 days in home use as well as safety over 6 months in home use. Methods This was a prospective, open label trial involving 32 adults meeting diagnostic criteria for primary insomnia who previously had participated in a 2 night in lab EEG sleep study. In the current study, participants received an additional 30 nights in home treatment, then had repeat EEG sleep studies performed to determine if effects noted at 2 nights remained durable after 30 days. Subjects also participated in an open label 6-month in-home use safety study. Results Baseline, 2-night and 30-night EEG sleep measures for sleep latency were 80.7 ± 73.8, 25.3 ± 22.6, 26.2 ±25.8 minutes (2- to 30-night difference p=0.81, NS) and for sleep efficiency were 67.4 ± 15.7, 81.4 ± 11.2, 83.2 ± 13.6 (2- to 30-night difference p=0.18, NS). Subjective sleep quality (0-100 scale with 100=best) at baseline, 2-night and 30-nights were 29.8 ± 15.2, 48.3 ± 20.2, 57.2 ± 21.1 (linear improvements significant over time p&lt;0.001). No adverse effects were seen across 6-months use. Conclusion Forehead cooling demonstrated durability of effects on EEG sleep measures from 2- to 30-nights use. Continuing improvements in subjective sleep quality when measured over time from baseline assessments to the end of the 30-night in-home use period were noted. Forehead cooling was safe over 6 months use in the home as evidenced by no serious device related adverse events. Support Ebb Therapeutics, Pittsburgh, PA 15222


Sign in / Sign up

Export Citation Format

Share Document